enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Thermo Fisher Scientific - Wikipedia

   en.wikipedia.org/wiki/Thermo_Fisher_Scientific

   Thermo Fisher Scientific's previous headquarters in Waltham, Massachusetts Thermo Fisher Scientific office in Canada. Thermo Fisher Scientific Inc. is an American life, science and clinical research company. It is a global supplier of analytical instruments, clinical development solutions, specialty diagnostics, laboratory, pharmaceutical and ...

3. Life Technologies - Wikipedia

   en.wikipedia.org/wiki/Life_Technologies

   Life Technologies Corporation was a biotech company founded in November 2008 through a US $6.7 billion merger of Invitrogen Corporation and Applied Biosystems Inc. The joint sales of the combined companies were about $3.5 billion; they had about 9,500 employees and owned more than 3,600 licenses and patents.

4. PPD, Inc. - Wikipedia

   en.wikipedia.org/wiki/PPD,_Inc.

   PPD was founded by Fred Eshelman, Pharm.D., as a one-person consulting firm in 1985. The following year, he expanded the company's scope to include development services and relocated operations from Maryland to North Carolina. July 1985: Fred Eshelman, Pharm.D., founds PPD as a one-person consulting firm based in his home in Maryland.

5. Invitrogen - Wikipedia

   en.wikipedia.org/wiki/Invitrogen

   Invitrogen is one of several brands under the Thermo Fisher Scientific corporation. The product line includes various subbrands of biotechnology products, such as machines and consumables for polymerase chain reaction, reverse transcription, cloning, culturing, stem cell production, cell therapy, regenerative medicine, immunotherapy, transfection, DNA/RNA purification, diagnostic tests ...

6. Patheon - Wikipedia

   en.wikipedia.org/wiki/Patheon

   Patheon is a service brand within Thermo Fisher Scientific's brand portfolio.Contract development and manufacturing organization (CDMO) services offered under the Patheon brand include small molecule API, biologics, viral vectors, cGMP plasmids, formulation, clinical trials solutions, logistics and commercial manufacturing and packaging.

7. Qiagen - Wikipedia

   en.wikipedia.org/wiki/Qiagen

   The acquisition offer was terminated on August 13, 2020, having only reached the threshold of 47% shareholder approval, below the minimum 66.6% required as per the agreement. Because of the lapsed offer, QIAGEN was required to reimburse $95 million to Thermo Fisher in expenses. [37]